https://en.bioecon.ru/clusters/market-access-commercial/Recent content in Market-Access-Commercial on BioeconHugoen-USSun, 05 Jul 2026 11:28:49 +0700https://en.bioecon.ru/technology/fermentation-capacity-brokerage/Sun, 05 Jul 2026 00:00:00 +0000https://en.bioecon.ru/technology/fermentation-capacity-brokerage/Matching platforms and contract manufacturers that connect biotech companies needing fermentation capacity with idle or available bioreactor capacity, easing the scale-up bottleneck between lab-scale precision fermentation and commercial-volume production.https://en.bioecon.ru/technology/named-patient-compassionate-use/Sun, 28 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/named-patient-compassionate-use/Regulated pre-approval access to investigational biopharmaceuticals for patients with serious or life-threatening disease and no satisfactory alternative — operated as a managed-access service spanning eligibility, regulatory submission, GMP drug sourcing and pharmacovigilance.https://en.bioecon.ru/technology/local-manufacturing-for-market-access/Wed, 24 Jun 2026 00:00:00 +0000https://en.bioecon.ru/technology/local-manufacturing-for-market-access/Contract development, technology-transfer and local-build services that establish in-country or regional biomanufacturing so a biologic or vaccine qualifies for market access, procurement preference and supply security in target jurisdictions.